Compound Summary
Compound Information
NAPROXEN
Compound Name: | NAPROXEN |
Compound CID: | 156391 |
Synonyms: | NAPROXEN 22204-53-1 (S)-Naproxen (+)-Naproxen Naprosyn More... |
Iupac Name: | (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
InChI: | InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1 |
InChIKey: | CMWTZPSULFXXJA-VIFPVBQESA-N |
Canonical Smiles: | CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O |
Isomeric Smiles: | C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O |
Molecular Weight: | 230.26 |
Molecular Formula: | C14H14O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
NAPROXEN
Molecular Weight: | 230.26 |
Molecular Formula: | C14H14O3 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 17 |
Complexity: | 277 |
Synonyms
NAPROXEN
| NAPROXEN | NAPROXEN |
|---|---|
NAPROXEN |
22204-53-1 |
(S)-Naproxen |
(+)-Naproxen |
Naprosyn |
Equiproxen |
Naproxene |
(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
Aleve |
(S)-(+)-Naproxen |
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid |
Laraflex |
d-Naproxen |
Naproxenum |
Calosen |
Naprosyne |
Naproxeno |
Nycopren |
Bonyl |
Naixan |
Reuxen |
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
Axer |
(+)-(S)-Naproxen |
Ec-Naprosyn |
naproxen(+) |
Acusprain |
Anexopen |
Arthrisil |
Artrixen |
Artroxen |
Bipronyl |
Clinosyn |
Danaprox |
Flexipen |
Leniartil |
Novonaprox |
Anaprox |
Apronax |
Artagen |
Atiflan |
Congex |
Daprox |
Genoxen |
Lefaine |
Nafasol |
Nalyxan |
Napflam |
Napmel |
Naposin |
Napren |
Naprius |
Veradol |
Fuxen |
Naxen |
Naxyn |
Xenar |
Dysmenalgit N |
Apo-Naproxen |
Floginax |
(S)-2-(6-Methoxy-2-naphthyl)propionic acid |
(+)-2-(6-Methoxy-2-naphthyl)propionic acid |
(+)-2-(Methoxy-2-naphthyl)-propionic acid |
RS-3540 |
(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
Dysmenalgit |
Diocodal |
(S)-2-(6-Methoxy-2-naphthyl)propanoic acid |
Prexan |
Apo-Napro-NA |
d-2-(6-Methoxy-2-naphthyl)propionic acid |
(+)-2-(Methoxy-2-naphthyl)-propionsaeure |
UNII-57Y76R9ATQ |
(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
Proxen |
CG 3117 |
CHEBI:7476 |
(2S)-2-(6-methoxy-2-naphthyl)propanoic acid |
CHEMBL154 |
Laser |
57Y76R9ATQ |
d-2-(6-Methoxy-2-naphthyl)-propionsaeure |
Naprium |
Naprux |
MFCD00010500 |
Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)- |
Duk |
Headlon |
Napratec |
Naprontag |
Narocin |
Naxopren |
Prafena |
Priaxen |
Pronaxen |
Rheumaflex |
Saritilron |
Sinartrin |
Soproxen |
Sutolin |
Tohexen |
Traumox |
Flexen |
Napxen |
Noflam |
Patxen |
Rahsen |
Sinton |
Sutony |
Velsay |
Vinsen |
Narma |
Roxen |
Anax |
CAS-22204-53-1 |
Flanax Forte |
Napren E |
Naprosyn LLE |
Proxen LE |
Naxen F |
Proxen LLE |
U-Ritis |
Naprosyn LLE Forte |
(S)-2-(6-Methoxy-naphthalen-2-yl)-propionic acid |
Naproxi 250 |
Naproxi 500 |
(S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid |
Naxyn 250 |
Naxyn 500 |
Equiproxen (Veterinary) |
Naproxene INN-French |
Naproxenum INN-Latin |
(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid |
Naproxeno INN-Spanish |
26159-31-9 |
Xenar-CR |
CCRIS 5265 |
HSDB 3369 |
EINECS 244-838-7 |
RS 3540 |
(S)-(+)-6-Methoxy-alp.-methyl-2-naphthalene acetic acid |
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)- |
Naprolag |
Naprosine |
Naprosy |
Panoxen |
Proxine |
Mnpa |
SR-01000075977 |
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)- |
DL Naproxen |
Naprosyn (TN) |
Naproxen,(S) |
NPS |
Prestwick_349 |
(+)-2-(Methoxy-2-naphthyl)-propionsaeure German |
Naproxen USAN:USP:INN:BAN:JAN |
d-2-(6-Methoxy-2-naphthyl)-propionsaeure German |
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)- |
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)- |
Spectrum_000977 |
4or0 |
4po0 |
(S)-(+)-Naproxene |
Prestwick0_000791 |
Prestwick1_000791 |
Prestwick2_000791 |
Spectrum2_001043 |
Spectrum3_000514 |
Spectrum4_000069 |
Spectrum5_001327 |
(+)NAPROXEN |
Naproxen2-(6-Methoxy-naphthalen-2-yl)-propionic acid |
Epitope ID:139974 |
UPCMLD-DP001 |
2-(6-Methoxy-naphthalen-2-yl)-propionic acid(Naproxen) |
EC 244-838-7 |
SCHEMBL3046 |
DSSTox_CID_20686 |
DSSTox_RID_79542 |
DSSTox_GSID_40686 |
Lopac0_000792 |
BSPBio_002067 |
KBioGR_000597 |
KBioSS_001457 |
ARONIS24306 |
BIDD:GT0062 |
DivK1c_000242 |
SPECTRUM1500425 |
Naproxen (JP17/USP/INN) |
SPBio_000966 |
SPBio_002861 |
GTPL5230 |
DTXSID4040686 |
UPCMLD-DP001:001 |
CMWTZPSULFXXJA-VIFPVBQESA- |
HMS500M04 |
KBio1_000242 |
KBio2_001457 |
KBio2_004025 |
KBio2_006593 |
KBio3_001567 |
Naproxen 1.0 mg/ml in Methanol |
PN400 COMPONENT NAPROXEN |
NINDS_000242 |
HMS1920P13 |
HMS2089N21 |
HMS2091H12 |
HMS3649M13 |
HMS3886C15 |
Pharmakon1600-01500425 |
ZINC105216 |
ACT02593 |
Tox21_301953 |
BDBM50339185 |
CCG-40130 |
NSC750183 |
NSC757239 |
AKOS005267223 |
AC-1363 |
DB00788 |
MCULE-2589082817 |
ME-0100 |
NSC 750183 |
NSC 757239 |
NSC-750183 |
NSC-757239 |
SDCCGSBI-0050769.P005 |
IDI1_000242 |
Naproxen 100 microg/mL in Acetonitrile |
Naproxen solution 1.0 mg/ml in methanol |
NCGC00016759-01 |
NCGC00016759-02 |
NCGC00016759-03 |
NCGC00016759-38 |
NCGC00021127-01 |
NCGC00161591-01 |
NCGC00255562-01 |
HY-15030 |
Naproxen, meets USP testing specifications |
SBI-0050769.P004 |
AM20060551 |
M1021 |
S5177 |
W4580 |
Naproxen, VETRANAL(TM), analytical standard |
(2S)-2-(6-Methoxynaphth-2-yl)propanoic acid |
(S)-2-(6-methoxy-2-naphthyl)-propionic acid |
04N531 |
C01517 |
D00118 |
J10145 |
O10203 |
(2S)-2-(6-methoxy(2-naphthyl))propanoic acid |
AB00052049-04 |
AB00052049_05 |
(+)(S)2-(6-methoxy-2-naphthyl)-propionic acid |
2-(6-Methoxy-2-naphthyl)propanoic acid , (+)- |
SR-01000003110 |
Q-201447 |
Q1215575 |
SR-01000003110-5 |
SR-01000075977-3 |
SR-01000075977-4 |
(+)-6-Methoxy-.alpha.-methyl-2-napthaleneacetic acid |
BRD-K59197931-001-02-9 |
BRD-K59197931-001-03-7 |
BRD-K59197931-236-09-6 |
SR-01000075977-10 |
(+)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid |
(alphas)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid |
(S)-(+)-2-(6-methoxy-naphthalen-2-yl)-propionic acid |
(S)-6-Methoxy-.alpha.-methyl-2-naphthalene acetic acid |
Naproxen, British Pharmacopoeia (BP) Reference Standard |
Naproxen, European Pharmacopoeia (EP) Reference Standard |
(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, 98% |
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (+)- |
Naproxen, United States Pharmacopeia (USP) Reference Standard |
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)- (8CI) |
Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material |
Naproxen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
131991-52-1 |
d-Naproxen; (2S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid; (S)-6-Methoxy-?-methyl-2-naphthaleneacetic Acid; d-2-(6-Methoxy-2-naphthyl)propionic Acid |
Experimental Data
NAPROXEN
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brachionus manjavacas | 1 | umol/L | 32 | S | B. manjavacas | 29340835 | Active |
Experimental Data Visualization
NAPROXEN
Statistics Data
NAPROXEN
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Brachionus manjavacas | 32 | 1 | 1 |
Statistics Data Visualization
NAPROXEN
